Intravenous Immunoglobulin in the Treatment of Autoimmune Neuromuscular Diseases:Present Status and Practical Therapeutic Guidelines
Muscle & Nerve 22:1479-1497, Dalakas,M.C., 1999
Insomnia for 5 Years
Lancet 354:1966, Lieb,K.,et al, 1999
Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease
Ann Int Med 131:919-926, Shadick,N.A.,et al, 1999
Neuro-Ophthalmic Manifestations of Diabetes
Ophthalmology 106:1047-1048, Sadun,A.A., 1999
Pediatric Third, Fourth, and Sixth Nerve Palsies:A Population-Based Study
Am J Ophthalmol 127:388-392, Holmes,J.M.,et al, 1999
Effect of Aldose Reductase Inhibition on Nerve Conduction and Morphomedtry in Diabetic Neuropathy
Neurol 53:580-591, Greene,D.A.,et al, 1999
Optic Nerve Enlargement in Krabbe's Disease
AJNR 20:1228-1231, Jones,B.V.,et al, 1999
Neurologic Complications Associated with Hepatitis C Virus Infection
Neurol 53:861-864, Tembl,J.I.,et al, 1999
Isolated Trochlear Nerve Palsy in Patients with Multiple Sclerosis
Neurol 53:877-879, Jacobson,D.M.,et al, 1999
Rehabilitation of Persons With Traumatic Brain Injury
JAMA 282:974-983,989, NIH Consensus Development Panel on Rehab with TBI, 1999
Multiple Sclerosis That is Progressive From the Time of Onset, Clinical Characteristics and Progression of Disability
Arch Neurol 56:1138-1142, Andersson,P.B.,et al, 1999
Safety and Factors Related to Survival After Percutaneous Endoscopic Gastrostomy in ALS
Neurol 53:1123-1125, Chio,A.,et al, 1999
Brachial Amyotrophic Diplegia, A Slowly Progressive Motor Neuron Disorder
Neurol 53:1071-1076, Katz,J.S.,et al, 1999
Isolated Superior Oblique Palsies with Brainstem Lesions
Neurol 53:1126-1127, Thomke,F.&Ringel,K., 1999
New Developments in the Neurobiology of the Tuberous Sclerosis Complex
Neurol 53:1384-1390, Crino,P.B.&Henske,E.P., 1999
SIADH as the First Symptom of Guillain-Barre Syndrome
Neurol 53:1365, Hofmann,O.,et al, 1999
An Algorithm for ALS Diagnosis and Management
Neurol 53:S58-S62, Swash,M., 1999
The Roussy-Levy Family:From the Original Description to the Gene
Ann Neurol 46:770-773, Plante-Bordeneuve,V.,et al, 1999
Bilateral Substantia Nigra Changes on MRI in a Patient with Encephalitis Lethargica
Neurol 53:1860-1862, Kun,L.N.,et al, 1999
Cervical Root Stimulation in a Case of Classic Neurogenic Thoracic Outlet Syndrome
Muscle & Nerve 22:1287-1292, Felice,K.J.,et al, 1999
Hypertrophy of Multiple Cranial Nerves and Spinal Roots in Chronic Inflammatory Demyelinating Neuropathy
JNNP 67:685-687, Duarte,J.,et al, 1999
Isolated Cranial Nerve Palsies Due to Brainstem Lesions
Muscle & Nerve 22:1168-1176, Thomke,F., 1999
Compression of Spinal Cord and Cauda Equina in Charcot-Marie-Tooth Disease Type 1A
Neurol 52:890-891, Butefisch,C.,et al, 1999
Spastic Paraparesis after Anaesthesia
Lancet 353:554, Lee,P.,et al, 1999
Pain after Whiplash:A Prospective Controlled Inception Cohort Study
JNNP 66:279-283, Obelieniene,D.,et al, 1999
A Critical Appraisal of the Chronic Whiplash Syndrome
JNNP 66:273-276, Pearce,J.M.S., 1999
Clinicopath Conf,Guillain-Barre Syndrome, Campylobacter Jejuni Enteritis,Case 39-1999
NEJM 341:1996-2003, , 1999
Quantitative MRI in Patients with Clinically Isolated Syndromes Suggestive of Demyelination
Neurol 52:599-606, Sailer,M.,et al, 1999
The Heidenhain Variant of Creutzfeldt-Jakob Disease
Arch Neurol 56:55-61, Kropp,S.,et al, 1999
Fatal Guillain-Barre Syndrome
Neurol 52:635-638, Lawn,N.D.&Wijdicks,E.F.M., 1999
The Association Between Sleep Apnea and the Risk of Traffic Accidents
NEJM 340:847-851,881, Teran-Santos,J.,et al, 1999
Oculogyric Crisis as an Initial Manifestation of Wilson's Disease
Neurol 52:714-715, Lee,M.S.,et al, 1999
Fibromyalgia Syndrome a Decade Later
Arch Int Med 159:777-785, Goldenberg,D.L., 1999
Risk Factors for Seizure-Related Motor Vehicle Crashes in Patients with Epilepsy
Neurol 52:1324-1329,1306, Krauss,G.L.,et al, 1999
Physician Assistants in Neurology Practice
Neurol 52:1513, Taft,J.M.&Hooker,R.S., 1999
Burden of Migraine in the United States, Disability and Economic Costs
Arch Int Med 159:813-818, Hu,X.H.,et al, 1999
Changes in Resource Use and Outcomes for Patients with Migraine Treated with Sumatriptan, A Managed Care Perspective
Arch Int Med 159:857-863, Lofland,J.H.,et al, 1999
Outcome in Severe Pediatric Guillain-Barre Syndrome after Immunotherapy or Supportive Care
Neurol 52:1494-1497, Graf,W.D.,et al, 1999
Atypical Form of Amyotrophic Lateral Sclerosis
JNNP 66:581-585, Sasaki,S.&Iwata,M., 1999
Practice Parameter:The Care of the Patient with Amyotrophic Lateral Sclerosis (An Evidence-Based Review), Report of the Quality Standards Subcommittee of the AAN
Neurol 52:1311-1323, Miller,R.G.,et al, 1999
Clumsiness, Confusion, Coma, and Valproate
Lancet 353:1408, Ellaway,C.J.,et al, 1999
Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999
Chronic Cryptogenic Sensory Polyneuropathy,Clinical and Laboratory Characteristics
Arch Neurol 56:540-547, 519, Wolfe,G.I.,et al, 1999
MR Imaging of Dejerine-Sottas Disease
AJNR 20:378-380, Make,D.D.,et al, 1999
Brain Structure and Neurocognitive and Behavioural Function in Adolescents Who Were Born Very Preterm
Lancet 353:1653-1657, Stewart,A.L.,et al, 1999
Clinicopath Conf:Lymphoplasmocytic Lymphoma with Motor Neuronopathy,Waldenstrom's Macroglobulinemia
NEJM 340:1661-1669, , 1999
Falling Asleep at the Wheel:Motor Vehicle Mishaps in Persons Taking Pramipexole and Ropinirole
Neurol 52:1908-1910, Frucht,S.,et al, 1999
Molecular Basis of the Neurodegenerative Disorders
NEJM 340:1970-1980, Martin,J.B., 1999
Pain and the Guillain-Barre Syndrome in Children Under 6 Years
J Pediatr 134:773-776, Nguyen,D.K.,et al, 1999
A Prospecitve Study of Preferences and Actual Treatment Choices in ALS
Neurol 53:278-283,248, Albert,S.M.,et al, 1999